Redeye updates its estimates and valuation after Lagercrantz’s Q3 2025/2026 report.
Redeye provides its initial take on Lagercrantz’s Q3 2025/2026 report, which showed strong EBITA growth of 20% y/y, beating our forecast by ...
Redeye updates its estimates and valuation after Lagercrantz’s Q2 2025/2026 report.
Redeye provides its initial take on Lagercrantz’s Q2 2025/2026 report, which featured an EBITA that roughly aligned with what we pencilled i...
Redeye updates its estimates and valuation following Lagercrantz’s Q1 2025/2026 report.
Redeye interviews Lagercrantz’s CEO, Jörgen Wigh. We discuss the company’s solid Q1 figures, recent M&A, and how it continues to execute in ...
Redeye provides its initial take on Lagercrantz’s Q1 2025/2026 report, which came in slightly below our estimates.
Redeye believes Lagercrantz continued its stable trend and ended fiscal year 2024/2025 in a solid fashion.
Redeye retains its positive view of Lagercrantz after a Q4 report that aligned with our projections.
Redeye's view is that Lagercrantz reported another strong quarter in a challenging market.
Redeye retains its positive view on Lagercrantz following a Q3 report in-line with our estimates.
Redeye thinks that Lagercrantz reported another stable quarter in a challenging market.
Redeye retains its positive view on Lagercrantz following a Q2 report in-line with our estimates.
Redeye expects a stable Q2 report from Lagercrantz with muted organic growth yet solid margins.
Redeye thinks that Lagercrantz reported a solid quarter despite a drop in organic sales.
Redeye retains its positive view on Lagercrantz following a Q1 report in-line with our estimates.
We have talked to Lagercrantz's CEO, Jörgen Wigh, and VP Niche Products Divsion, Jonas Ahlberg, about the Q4 report.
Redeye retains its positive view on Lagercrantz following a Q4 report in-line with our estimates.
Redeye views the announced large acquisition of Prido as positive and increase both the near-term estimates and long-term estimates.
Redeye thinks that Lagercrantz yet again showed resiliency with strong margins and cash flow despite a drop in organic sales.
Redeye updates its estimates for Lagercrantz following a Q3 acquisition spree, along with FX adjustments due to the strenghtening SEK.
Något negativ organisk tillväxt… Den organiska tillväxten var svagt negativ i Q2, vilket vi bedömer beror på att prishöjningarna, som har va...
Redeye believes the Q2 report from Lagercrantz was strong, especially from a profit perspective, and that the signals from management indica...
Redeye retains its positive view on Lagercrantz following a Q2 report with strong margins.
Stabil tillväxt med imponerande marginalexpansion Förvärv har historiskt stått för två tredjedelar av tillväxten.
6% organisk tillväxt… Marknadsläget är fortsatt stabilt för de flesta av koncernens verksamheter och den befarade nedgången har än så länge ...
Redeye believes the Q1 report from Lagercrantz was strong, especially from a profit perspective, and that the signals from management indica...
Redeye retains its positive view on Lagercrantz following a Q1 report with 6% organic growth and strong margins.
Organiska tillväxten är fortsatt god och marginalerna är stabila på en hög nivå 9% organisk tillväxt i kvartalet markerar det åttonde kvarta...
Redeye retains its positive view on Lagercrantz following a solid Q4 report with 9% organic growth and healthy margins.
Redeye retains its positive view on Lagercrantz following a Q4 report with 9% organic growth and healthy margins.
Fortsatt hög organisk tillväxt Lagercrantz rapporterade 10% organisk tillväxt i Q3 och även om tillväxttakten har minskat är trenden fortsat...
Redeye retains its positive view on Lagercrantz following a solid Q3 report with 10% organic growth and healthy margins.
Redeye retains its positive view on Lagercrantz following a Q3 report with 10% organic growth and healthy margins.
Fortsatt stark efterfrågan… Lagercrantz växte försäljningen 11% organiskt och är därmed på rekordhöga nivåer.
Redeye retains its positive take on Lagercrantz following a solid Q2.
Redeye retains its positive view on Lagercrantz following a solid Q2 report with 11% organic growth and healthy margins.
Redeye updates its estimates for the Q2 report due to three announced acquisitions during the quarter and lowers its valuation range due to ...
Redeye retains its positive take on Lagercrantz following a solid Q1.
9% organisk tillväxt trots höga jämförelsetal... Trots svåra jämförelsetal rapporterade Lagercrantz organisk tillväxt på 9% med förvärv som ...
Redeye retains its positive view on Lagercrantz following a solid Q1 report with 9% organic growth and healthy margins.
Redeye retains its positive take on Lagercrantz following a solid Q4 report showing strong growth and highlighting the group’s pricing power...
Fortsatt starkt affärsläge... Lagercrantz rapporterade en organisk tillväxt på 20% där förvärv bidrog med 17%.
Redeye retains its positive view on Lagercrantz following the Q4 report showing an impressive 20% organic growth.
Fortsatt starkt affärsläge Lagercrantz rapporterade organisk tillväxt på 14% och förvärv som bidrog med 16%.
Fortsatt starkt affärsläge... Lagercrantz rapporterade organisk tillväxt på 13% med förvärv som bidrog med 19%.
Mycket stark Q1... Lagercrantz rapporterade organisk tillväxt på imponerande 18% med förvärv som bidrog med lika mycket.
Redeye raises its forecasts and Base case for Lagercrantz following an excellent Q2 report with an impressive organic growth of 18% and reco...
Impressing volumes and profitability Lagercrantz continues to impress, both on sales and margins, with sales growing 33% y-o-y (organically ...
Redeye sees an excellent Q1 21/22 report from Lagercrantz, where the organic growth and margins beat our forecasts significantly.
Q1 expectations Lagercrantz should have a solid Q1’21/22.
